A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
Clinical trial NCT07481383 · RECRUITING
Trial details
- NCT number
- NCT07481383
- Sponsor
- Continuity Biosciences, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-11
- Primary completion
- 2027-08-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.